206 related articles for article (PubMed ID: 19362861)
21. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
[TBL] [Abstract][Full Text] [Related]
22. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
Simons JW; Carducci MA; Mikhak B; Lim M; Biedrzycki B; Borellini F; Clift SM; Hege KM; Ando DG; Piantadosi S; Mulligan R; Nelson WG
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3394-401. PubMed ID: 16740763
[TBL] [Abstract][Full Text] [Related]
24. Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells.
Gao L; Fan HH; Lu HZ; Nie XX; Liu Y; Yang YM; Qian KC; Gao F
Transfusion; 2007 Feb; 47(2):256-65. PubMed ID: 17302772
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.
Erhardt M; Schmidt-Wolf IG; Sievers E; Frank S; Strehl J; von Lilienfeld-Toal M; Gorschlüter M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):403-9. PubMed ID: 17122879
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
[TBL] [Abstract][Full Text] [Related]
27. [Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells].
Shi YJ; Ren HY; Cen XN; Dong YJ; Ma MX; Zhao YL; Zhu Y; Yu JR
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):107-11. PubMed ID: 18646691
[TBL] [Abstract][Full Text] [Related]
28. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
Draube A; Beyer M; Schumer S; Thomas RK; von Tresckow B; Koslowsky TC; Krieglstein CF; Schultze JL; Wolf J
J Immunother; 2007; 30(4):359-69. PubMed ID: 17457211
[TBL] [Abstract][Full Text] [Related]
29. Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells.
Seo MJ; Kim GR; Son YM; Yang DC; Chu H; Min TS; Jung ID; Park YM; Han SH; Yun CH
Mol Immunol; 2011 Sep; 48(15-16):1744-52. PubMed ID: 21632112
[TBL] [Abstract][Full Text] [Related]
30. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
Zhou CJ; Ma W; Zhou JD; Zhao YX; Xie HQ
Ai Zheng; 2006 Feb; 25(2):143-7. PubMed ID: 16480575
[TBL] [Abstract][Full Text] [Related]
31. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
[TBL] [Abstract][Full Text] [Related]
32. Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines.
Liu QL; Wang YS; Wang JX
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):529-34. PubMed ID: 19822498
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro.
Li YG; Wang ZP; Tian JQ; Tian BQ; Rodrigues R; Shang PF; Zhang T
Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038
[TBL] [Abstract][Full Text] [Related]
34. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
36. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
[TBL] [Abstract][Full Text] [Related]
37. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
38. The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer.
Matera L
Cancer Treat Rev; 2010 Apr; 36(2):131-41. PubMed ID: 19954892
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
[TBL] [Abstract][Full Text] [Related]
40. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.
Liu Y; Chiriva-Internati M; You C; Luo R; You H; Prasad CK; Grizzi F; Cobos E; Klimberg VS; Kay H; Mehta JL; Hermonat PL
Cancer Gene Ther; 2005 Mar; 12(3):304-12. PubMed ID: 15565181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
